Publications

In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

 5
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

Tags:

Previous Article

Molecular mechanisms of endometriosis and comorbidities

Next Article

Predicting if multiple sclerosis medication will be effective for patients

Related Posts

GLP-1 programs the neurovascular landscape

GLP-1 programs the neurovascular landscape

 66

Drosophila appear resistant to trans-synaptic tau propagation

Drosophila appear resistant to trans-synaptic tau propa...

 51

Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation

Secreted neurofilament light chain after neuronal damag...

 70